|
|
||||||||
Clinical Chemistry, Vol 39, 1435-1439, Copyright © 1993 by American Association for Clinical Chemistry
S Madersbacher, T Shu-Chen, S Schwarz, S Dirnhofer, G Wick and P Berger
Institute for Biomedical Aging Research, Austrian Academy of Sciences, Innsbruck.
The influence of assay design and quantification system on assay performance was investigated by developing, optimizing, and comparing a time-resolved immunofluorometric assay (IFMA), an immunoenzymometric assay (IEMA), an immunoradiometric assay (IRMA), and a competitive radioimmunoassay (RIA), all performed with the same monoclonal antibodies (MCA) directed against human follicle-stimulating hormone (hFSH). The lowest detection limit (2 ng/L for hFSH-I-3, corresponding to 2.5 mIU of 1st International Reference Preparation of hFSH 78/549 per liter), the widest measuring range (2-160,000 ng/L), and the greatest signal-to-noise ratio (13,000:1 at 160,000 ng/L) were obtained in the IFMA. For analysis of serum samples from 101 male (ages 2-91 years) and 99 female (ages 2-90 years) individuals at a single dilution, 100% of samples were within the measuring range of the IFMA, whereas only 87%, 55%, 32%, and 8% of the sera were for the IRMA, the IEMA evaluated with double-wavelength measurement, the conventional IEMA, and the competitive MCA-based RIA, respectively. These studies demonstrate clear advantages of the IFMA in sensitivity and assay range, which allows reliable and cost- and time-effective determination of hFSH in individuals from infancy to senescence.
The following articles in journals at HighWire Press have cited this article:
![]() |
M. Jimenez, J.A. Spaliviero, A.J. Grootenhuis, J. Verhagen, C.M. Allan, and D.J. Handelsman Validation of an Ultrasensitive and Specific Immunofluorometric Assay for Mouse Follicle-Stimulating Hormone Biol Reprod, January 1, 2005; 72(1): 78 - 85. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Birken, P. Berger, J.-M. Bidart, M. Weber, A. Bristow, R. Norman, C. Sturgeon, and U.-H. Stenman Preparation and Characterization of New WHO Reference Reagents for Human Chorionic Gonadotropin and Metabolites Clin. Chem., January 1, 2003; 49(1): 144 - 154. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Kanda, A. Jablonka-Shariff, A. Sato, M. R. Pixley, E. Bos, T. Hirooka, D. Ben-Menahem, and I. Boime Genetic Fusion of an {alpha}-Subunit Gene to the Follicle-Stimulating Hormone and Chorionic Gonadotropin-{beta} Subunit Genes: Production of a Bifunctional Protein Mol. Endocrinol., November 1, 1999; 13(11): 1873 - 1881. [Abstract] [Full Text] |
||||
![]() |
P. Schwarzler, G. Untergasser, M. Hermann, S. Dirnhofer, B. Abendstein, S. Madersbacher, and P. Berger Selective Growth Hormone/Placental Lactogen Gene Transcription and Hormone Production in Pre- and Postmenopausal Human Ovaries J. Clin. Endocrinol. Metab., October 1, 1997; 82(10): 3337 - 3341. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Rong, L. J Deftos, H. Ji, and E. Bucht Two-site immunofluorometric assay of intact salmon calcitonin with improved sensitivity Clin. Chem., January 1, 1997; 43(1): 71 - 75. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |